Global C-MET/HGF Inhibitors Competitive Landscape Professional Research Report 2024

Research Summary

C-MET/HGF inhibitors are a class of targeted therapy drugs that specifically target the C-MET receptor and its ligand, hepatocyte growth factor (HGF). C-MET is a receptor tyrosine kinase that plays a crucial role in cell growth, survival, migration, and invasion, and its overactivation is often associated with cancer development and progression. HGF is the natural ligand that binds to C-MET and activates its signaling pathway. By inhibiting the interaction between C-MET and HGF, these inhibitors block the downstream signaling pathways that promote tumor growth and metastasis. C-MET/HGF inhibitors have shown promise as potential treatments for various types of cancer, including lung, gastric, and kidney cancers. They are typically used in combination with other therapies or as a targeted monotherapy in patients with tumors that express high levels of C-MET and are refractory to standard treatments. Clinical trials are ongoing to further evaluate the safety and efficacy of C-MET/HGF inhibitors in cancer treatment.

According to DIResearch's in-depth investigation and research, the global C-MET/HGF Inhibitors market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of C-MET/HGF Inhibitors include Exelixis, Ipsen, Pfizer, Novartis, Takeda, Merck KGaA, Merck, Daiichi Sankyo, GSK, Bristol-Myers Squibb(BMS), AVEO Pharmaceuticals, Roche, Amgen, AstraZeneca, Mirati Therapeutics, Eli Lilly, Johnson & Johnson, Eisai, Hutchison MediPharma, Kringle Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of C-MET/HGF Inhibitors. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global C-MET/HGF Inhibitors market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the C-MET/HGF Inhibitors market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of C-MET/HGF Inhibitors industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of C-MET/HGF Inhibitors Include:

Exelixis

Ipsen

Pfizer

Novartis

Takeda

Merck KGaA

Merck

Daiichi Sankyo

GSK

Bristol-Myers Squibb(BMS)

AVEO Pharmaceuticals

Roche

Amgen

AstraZeneca

Mirati Therapeutics

Eli Lilly

Johnson & Johnson

Eisai

Hutchison MediPharma

Kringle Pharmaceuticals

C-MET/HGF Inhibitors Product Segment Include:

Cabozantinib

Crizotinib

Others

C-MET/HGF Inhibitors Product Application Include:

Hospital

Drug Store

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global C-MET/HGF Inhibitors Industry PESTEL Analysis

Chapter 3: Global C-MET/HGF Inhibitors Industry Porter's Five Forces Analysis

Chapter 4: Global C-MET/HGF Inhibitors Major Regional Market Size and Forecast Analysis

Chapter 5: Global C-MET/HGF Inhibitors Market Size and Forecast by Type and Application Analysis

Chapter 6: North America C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa C-MET/HGF Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global C-MET/HGF Inhibitors Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 C-MET/HGF Inhibitors Market Overview

1.1 Product Definition and Statistical Scope

1.2 C-MET/HGF Inhibitors Product by Type

1.2.1 Global C-MET/HGF Inhibitors Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cabozantinib

1.2.3 Crizotinib

1.2.4 Others

1.3 C-MET/HGF Inhibitors Product by Application

1.3.1 Global C-MET/HGF Inhibitors Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Drug Store

1.4 Global C-MET/HGF Inhibitors Market Revenue Analysis (2019-2030)

1.5 C-MET/HGF Inhibitors Market Development Status and Trends

1.5.1 C-MET/HGF Inhibitors Industry Development Status Analysis

1.5.2 C-MET/HGF Inhibitors Industry Development Trends Analysis

2 C-MET/HGF Inhibitors Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 C-MET/HGF Inhibitors Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global C-MET/HGF Inhibitors Market Analysis by Regions

4.1 C-MET/HGF Inhibitors Overall Market: 2023 VS 2024 VS 2030

4.2 Global C-MET/HGF Inhibitors Revenue and Forecast Analysis (2019-2030)

4.2.1 Global C-MET/HGF Inhibitors Revenue and Market Share by Region (2019-2024)

4.2.2 Global C-MET/HGF Inhibitors Revenue Forecast by Region (2025-2030)

5 Global C-MET/HGF Inhibitors Market Size by Type and Application

5.1 Global C-MET/HGF Inhibitors Market Size by Type

5.2 Global C-MET/HGF Inhibitors Market Size by Application

6 North America

6.1 North America C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America C-MET/HGF Inhibitors Market Size by Type

6.4 North America C-MET/HGF Inhibitors Market Size by Application

6.5 North America C-MET/HGF Inhibitors Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe C-MET/HGF Inhibitors Market Size by Type

7.4 Europe C-MET/HGF Inhibitors Market Size by Application

7.5 Europe C-MET/HGF Inhibitors Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China C-MET/HGF Inhibitors Market Size by Type

8.4 China C-MET/HGF Inhibitors Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) C-MET/HGF Inhibitors Market Size by Type

9.4 APAC (excl. China) C-MET/HGF Inhibitors Market Size by Application

9.5 APAC (excl. China) C-MET/HGF Inhibitors Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America C-MET/HGF Inhibitors Market Size by Type

10.4 Latin America C-MET/HGF Inhibitors Market Size by Application

10.5 Latin America C-MET/HGF Inhibitors Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa C-MET/HGF Inhibitors Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa C-MET/HGF Inhibitors Market Size by Type

11.4 Middle East & Africa C-MET/HGF Inhibitors Market Size by Application

11.5 Middle East & Africa C-MET/HGF Inhibitors Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global C-MET/HGF Inhibitors Market Revenue by Key Manufacturers (2020-2024)

12.2 C-MET/HGF Inhibitors Competitive Landscape Analysis and Market Dynamic

12.2.1 C-MET/HGF Inhibitors Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Exelixis

13.1.1 Exelixis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Exelixis C-MET/HGF Inhibitors Product Portfolio

13.1.3 Exelixis C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Ipsen

13.2.1 Ipsen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Ipsen C-MET/HGF Inhibitors Product Portfolio

13.2.3 Ipsen C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Pfizer

13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Pfizer C-MET/HGF Inhibitors Product Portfolio

13.3.3 Pfizer C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Novartis

13.4.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Novartis C-MET/HGF Inhibitors Product Portfolio

13.4.3 Novartis C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Takeda

13.5.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Takeda C-MET/HGF Inhibitors Product Portfolio

13.5.3 Takeda C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Merck KGaA

13.6.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Merck KGaA C-MET/HGF Inhibitors Product Portfolio

13.6.3 Merck KGaA C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Merck

13.7.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Merck C-MET/HGF Inhibitors Product Portfolio

13.7.3 Merck C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Daiichi Sankyo

13.8.1 Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Daiichi Sankyo C-MET/HGF Inhibitors Product Portfolio

13.8.3 Daiichi Sankyo C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 GSK

13.9.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 GSK C-MET/HGF Inhibitors Product Portfolio

13.9.3 GSK C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Bristol-Myers Squibb(BMS)

13.10.1 Bristol-Myers Squibb(BMS) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Bristol-Myers Squibb(BMS) C-MET/HGF Inhibitors Product Portfolio

13.10.3 Bristol-Myers Squibb(BMS) C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 AVEO Pharmaceuticals

13.11.1 AVEO Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 AVEO Pharmaceuticals C-MET/HGF Inhibitors Product Portfolio

13.11.3 AVEO Pharmaceuticals C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Roche

13.12.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Roche C-MET/HGF Inhibitors Product Portfolio

13.12.3 Roche C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Amgen

13.13.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Amgen C-MET/HGF Inhibitors Product Portfolio

13.13.3 Amgen C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 AstraZeneca

13.14.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 AstraZeneca C-MET/HGF Inhibitors Product Portfolio

13.14.3 AstraZeneca C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Mirati Therapeutics

13.15.1 Mirati Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Mirati Therapeutics C-MET/HGF Inhibitors Product Portfolio

13.15.3 Mirati Therapeutics C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Eli Lilly

13.16.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Eli Lilly C-MET/HGF Inhibitors Product Portfolio

13.16.3 Eli Lilly C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Johnson & Johnson

13.17.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Johnson & Johnson C-MET/HGF Inhibitors Product Portfolio

13.17.3 Johnson & Johnson C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Eisai

13.18.1 Eisai Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Eisai C-MET/HGF Inhibitors Product Portfolio

13.18.3 Eisai C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Hutchison MediPharma

13.19.1 Hutchison MediPharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Hutchison MediPharma C-MET/HGF Inhibitors Product Portfolio

13.19.3 Hutchison MediPharma C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Kringle Pharmaceuticals

13.20.1 Kringle Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Kringle Pharmaceuticals C-MET/HGF Inhibitors Product Portfolio

13.20.3 Kringle Pharmaceuticals C-MET/HGF Inhibitors Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 C-MET/HGF Inhibitors Industry Chain Analysis

14.2 C-MET/HGF Inhibitors Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 C-MET/HGF Inhibitors Typical Downstream Customers

14.4 C-MET/HGF Inhibitors Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support